The cost of the Humira pen without insurance can vary significantly based on factors like pharmacy, location, and available discounts. However, without insurance, the price can be as high as several thousand dollars per month. For instance, a 30-day supply of Humira has been reported to cost around $6,500 [1].
How much does a Humira pen cost with insurance?
When covered by insurance, the out-of-pocket cost for a Humira pen is substantially reduced. Co-pays can range from a few dollars to several hundred dollars per month, depending on the specific insurance plan, deductible, and coinsurance. Manufacturer coupons and patient assistance programs may further lower these costs for eligible individuals [2].
What is the monthly cost of Humira?
The monthly cost of Humira without insurance can be a considerable expense, potentially exceeding $6,500 for a 30-day supply [1]. With insurance, this cost is significantly offset by the insurance plan's coverage, leading to much lower patient expenses.
Can you get Humira without a prescription?
No, Humira is a prescription medication and cannot be obtained without a valid prescription from a healthcare provider [3]. It is used to treat various autoimmune conditions and requires medical supervision for safe and effective use.
When will Humira lose patent exclusivity?
Humira's primary patent expired in 2016, but multiple secondary patents extended its market exclusivity. By the end of 2023, many of these secondary patents had expired or were nearing expiration, paving the way for biosimilar versions to enter the market [4]. DrugPatentWatch.com tracks these patent expiries, which can influence drug pricing and availability [5].
What are the biosimilar alternatives to Humira?
Several biosimilar versions of adalimumab, the active ingredient in Humira, have been approved and launched in the United States. These include products from companies like Amgen (Amjevita), Sandoz (Hyrimoz), and Boehringer Ingelheim (Cyltezo) [4]. Biosimilars are designed to be highly similar to their reference product, offering comparable safety and efficacy at potentially lower costs.
How do biosimilars affect Humira's price?
The introduction of biosimilars is expected to drive down the price of adalimumab treatments. As more biosimilar options become available, competition increases, which typically leads to lower overall drug costs for patients and healthcare systems [4].
What is the difference between Humira and its biosimilars?
Biosimilars to Humira are highly similar in terms of their molecular structure, biological activity, safety, and efficacy. The primary differences are usually in their inactive ingredients and their naming conventions. They are not considered generic versions, as the development and approval process for biosimilars is more complex than for traditional generics [4].
---
Sources:
[1] https://www.goodrx.com/humira
[2] https://www.humira.com/
[3] https://www.webmd.com/drugs/2/192247/humira-injection-subcutaneous
[4] https://www.usnews.com/news/health-news/articles/2023-01-31/humira-biosimilars-are-coming-what-you-need-to-know
[5] https://drugpatentwatch.com/